Einstein-Mount Sinai Diabetes Research Center

爱因斯坦西奈山糖尿病研究中心

• 批准号: 8872956
• 负责人: STREAMSON C CHUA
• 金额: $ 13.92万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-05-10 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8872956
• 关键词: Advertising; Area; Award; Budgets; Clinical; Clinical Sciences; Collaborations; Communities; Complications of Diabetes Mellitus; Core Facility; Data; Diabetes Mellitus; Discipline; Eligibility Determination; Ensure; Extramural Activities; Faculty; Feasibility Studies; Fostering; Funding; Funding Agency; Future; Generations; Goals; Grant; Individual; Institutes; Laboratories; Mentors; Metabolic Diseases; Metabolism; Mission; Modality; Modeling; Monitor; Obesity; Patient Care; Pilot Projects; Publications; Recording of previous events; Request for Applications; Research; Research Personnel; Scientist; Seeds; Services; Textiles; Translational Research; United States National Institutes of Health; base; cost effective; design; experience; improved; interest; member; novel; novel strategies; programs; success

The mission of the Pilot & Feasibility Study (P&F) Program is to provide initial support for new investigators, for established investigators to explore new directions, and to enable the Einstein-Mount Sinai Diabetes Research Center (ES-DRC) to attract scientists from other disciplines to diabetes research. The P&F Program is a vital component of the ES-DRC and has successfully promoted numerous new research endeavors in diabetes- related areas. This program constitutes a key interface among the Einstein, Mount Sinai and other regional academic communities at large, and serves as a major attraction in the recruitment of faculty and staff. Over the past 37 years the Center funded 113 feasibility studies from a pool of 449 applications (funding rate of 25.1%). These studies also include targeted efforts in this project period to increase the number of applications funded in our regional center at both the basic, clinical and translational diabetes efforts. We anticipate funding 7 Pilot & Feasibility grants at steady state, alternating between 4 new awards and 3 continuing awards, each year; typically, projects are funded for two years if sufficient progress is shown after the first year. The P&F study program has enabled recipients to obtain data and publications that constituted the basis for successful applications for extramural support. Under the same administrative umbrella as the Pilot & Feasibility program, we established a microgrant award program that provides specific support for the use of ES-DRC Core facilities. Last year, the microgrant program funded 8 awards out of 19 submitted applications. In addition, we also partner with the Einstein Clinical and Translational Science Award on a catalytic seed grant to support diabetes-specific translation research. These value added programs further enhance diabetes directed research efforts. To continue these established and new initiatives within the P&F program, we will: 1) advertise and organize the yearly P&F grant competition cycle; 2) support mechanisms for interaction and collaboration among established researchers in diabetes and related areas and for those who are new to the field; 3) provide mentoring and guidance for investigators who are new to diabetes research to facilitate generation of preliminary data with the goal of successful applications for NIH funding and other funding sources; 4) communicate responsibilities and opportunities to P&F awardees by integrating them into ES-DRC activities; 5) provide $10,000 of free use of each ES-DRC Biomedical Core services directly related to the funded P&F project; and 6) manage the institutionally microgrant and Catalytic Seed Grant Award programs in diabetes and metabolism.

试点和可行性研究（P&F）计划的使命是为新的研究人员提供初步支持， 建立了研究人员，以探索新的方向，并使爱因斯坦山西奈糖尿病研究 中心（ES-DRC）吸引其他学科的科学家参与糖尿病研究。P&F计划是一个重要的 ES-DRC的组成部分，并成功地促进了糖尿病的许多新的研究工作， 相关领域。该计划构成了爱因斯坦，西奈山和其他区域之间的关键接口 在整个学术界，并作为一个主要的吸引力，在招聘教师和工作人员。超过 在过去的37年里，该中心从449份申请中资助了113项可行性研究（资助率为 25.1%）。这些研究还包括在本项目期间有针对性地努力增加申请数量 在我们的区域中心资助的基础，临床和转化糖尿病的努力。我们预计， 稳定状态下的7个试点和可行性赠款，每个补助金在4个新补助金和3个持续补助金之间交替 一般来说，如果在第一年之后取得了足够的进展，则为项目提供两年的资金。P&F 研究计划使受援者能够获得数据和出版物，这些数据和出版物构成了成功的基础。 申请校外支持。在与试点和可行性计划相同的行政保护伞下， 我们建立了一个小额赠款奖励计划，为ES-DRC核心的使用提供具体的支持 设施去年，小额赠款计划资助了19个提交申请中的8个奖项。另外我们 还与爱因斯坦临床和转化科学奖合作，提供催化种子赠款，以支持 糖尿病特异性翻译研究这些增值计划进一步加强糖尿病指导 研究工作。为了在P&F计划中继续这些既定和新的举措，我们将：1） 宣传和组织年度P&F赠款竞争周期; 2）支持互动机制， 糖尿病及相关领域的知名研究人员之间的合作，以及那些新接触的人 3）为糖尿病研究新手提供指导和指导，以促进 生成初步数据，目标是成功申请NIH资金和其他资金 来源; 4）通过将P&F获奖者整合到ES-DRC中，向他们传达责任和机会 活动; 5）提供10，000美元的免费使用每个ES-DRC生物医学核心服务直接相关的 资助的P&F项目;以及6）管理机构小额赠款和催化种子赠款奖计划， 糖尿病和新陈代谢。